Sfoglia per Rivista  DIABETES/METABOLISM RESEARCH AND REVIEWS

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 1 a 20 di 71
Titolo Data di pubblicazione Autore(i) File
A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI) 1-gen-1999 Visalli, N; Cavallo, Mg; Signore, A; Baroni, Mg; Buzzetti, R; Fioriti, E; Mesturino, C; Fiori, R; Lucentini, L; Matteoli, Mc; Crino, A; Corbi, S; Spera, S; Teodonio, C; Paci, F; Amoretti, R; Pisano, L; Suraci, C; Multari, G; Sulli, N; Cervoni, M; De Mattia, G; Faldetta, Mrc; Boscherini, B; Bitti, Mlm; Marietti, G; Ferrazzoli, F; Bizzarri, C; Pitocco, D; Ghirlanda, G; Pozzilli, P
A tribute to Professor Domenico Andreani 1-gen-2019 Pozzilli, P
Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure 1-gen-2009 Chello, M; Spadaccio, C; Lusini, M; Covino, E; Blarzino, C; DE MARCO, F; DI DOMENICO, F; Coccia, R
Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitus. 1-gen-2017 Rizzo, P; Pitocco, D; Zaccardi, F; Di Stasio, E; Strollo, R; Rizzi, A; Scavone, G; Costantini, F; Galli, M; Tinelli, G; Flex, A; Caputo, S; Pozzilli, P; Landolfi, R; Ghirlanda, G; Nissim, A
Benefits of caloric restriction for cardiometabolic health, including type 2 diabetes mellitus risk 1-gen-2014 Soare, A; Weiss, Ep; Pozzilli, P
Blue eyes as a risk factor for type 1 diabetes 1-gen-2011 Di Stasio, E; Maggi, D; Berardesca, E; Marulli, Gc; Bizzarri, C; Lauria, A; Portuesi, R; Cavallo, Mg; Costantino, F; Buzzetti, R; Astorri, E; Pitocco, D; Songini, M; Pozzilli, P; IMDIAB Group:, M Altomare; Astorri, E; Barchetta, I; Benevento, D; G Beretta Anguissola, ; Bizzarri, C; Buzzetti, R; Capizzi, M; Cappa, M; R Cassone Faldetta, M; G Cavallo, M; Cipolloni, L; Cipponeri, E; Costantino, F; Crinò, A; E Di Stasio, ; Fioriti, E; Ghirlanda, G; Guglielmi, C; Lauria, A; Maddaloni, E; Maggi, D; Manfrini, S; R Maurizi, A; Moretti, C; Morviducci, L; Napoli, N; R Nardone, M; Palermo, A; Patera, P; Pitocco, D; Portuesi, R; Scrocca, R; Spera, S; Strollo, R; Suraci, C; Tubili, C; Tuccinardi, D; Valente, L; Visalli, N
Bovine beta-casein antibodies in breast- and bottle-fed infants: their relevance in Type 1 diabetes 1-gen-2001 Monetini, L; Cavallo, Mg; Stefanini, L; Ferrazzoli, F; Bizzarri, C; Marietti, G; Curro, V; Cervoni, M; Pozzilli, P
Challenges in developing endpoints for type 1 diabetes intervention studies 1-gen-2009 Cernea, S; Raz, I; Herold, Kc; Hirshberg, B; Roep, Bo; Schatz, Da; Fleming, Ga; Pozzilli, P; Little, R; Schloot, Nc; Leslielo, Rdg; Skyler, Js; Palmer, Jp
Characterization of endothelial progenitor cells in the NOD mouse as a source for cell therapies 1-gen-2009 Khoo, Cp; Valorani, Mg; Brittan, M; Alison, Mr; Warnes, G; Johansson, U; Hawa, M; Pozzilli, P
Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics 1-gen-2016 Pozzilli, P; Battelino, T; Danne, T; Hovorka, R; Jarosz-Chobot, P; Renard, E
Diabetes classification: grey zones, sound and smoke: Action LADA 1 1-gen-2008 Leslie, Rdg; Kolb, H; Schloot, Nc; Buzzetti, R; Mauricio, D; De Leiva, A; Yderstraede, K; Sarti, C; Thivolet, C; Hadden, D; Ter, S; Schernthaner, G; Scherbaum, W; Williams, R; Pozzilli, P
Diabetes in chronic liver disease: from old concepts to new evidence 1-gen-2006 Picardi, A; D'Avola, D; VESPASIANI GENTILUCCI, U; Galati, G; Fiori, E; Spataro, S; Afeltra, A
Diabetes in chronic liver disease: from the old concepts to the most recent evidences 1-gen-2006 Picardi, A; Davola, D; VESPASIANI GENTILUCCI, U; Galati, G; Fiori, E; Afeltra, A
Diabetes on demand and novel technologies 1-gen-2018 Maurizi, A; Piemonte, V; Pozzilli, P
Diabetic lung, an underrated complication from restrictive functional pattern to pulmonary hypertension 1-gen-2019 Fuso, L; Pitocco, D; Antonelli Incalzi, R
Diet can influence the ability of nicotinamide to prevent diabetes in the non-obese diabetic mouse: a preliminary study 1-gen-1999 Beales, Pe; Burr, La; Webb, Gp; Mansfield, Kj; Pozzilli, P
DPP4 inhibition: preventing SARS-CoV-2 infection and/or progression of COVID-19? 1-gen-2020 Strollo, R; Pozzilli, P
Editors' note to Raz and Eldor's commentary "Rational therapy for diabetes: early recognition of adverse effects and avoidance of disruptive false alarms". Diabetes Metab Res Rev 2012 1-gen-2012 Roth, J; Pozzilli, P
Effect of diet on type 2 diabetes mellitus: a review 1-gen-2014 Khazrai, Ym; Defeudis, G; Pozzilli, P
Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes 1-gen-2017 Guglielmi, C; Del Toro, R; Lauria, A; Maurizi, Ar; Fallucca, S; Cappelli, A; Angeletti, S; Lachin, Jm; Pozzilli, P
Mostrati risultati da 1 a 20 di 71
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile